---
title: Acclinate wins Anthem Award for DEI
description: ‍Birmingham, AL - January 30, 2024 – Acclinate, a trailblazer in advancing health equity through inclusive research, is thrilled to announce its win in the
image: https://blog.acclinate.com/hubfs/65bd67b47f81a0c18c101e2a_Anthem%20Awards%20Post.png
---

[![Acclinate Logo](https://blog.acclinate.com/hs-fs/hubfs/Acclinate-logo.png?width=2000&height=497&name=Acclinate-logo.png "Acclinate Logo")](https://www.acclinate.com/)

- Products 
    - [NOWINCLUDED](https://www.acclinate.com/products/nowincluded-the-community)
    - [eDICT](https://www.acclinate.com/products/e-dict)
- Solutions 
    - [Pharmaceutical Companies](https://www.acclinate.com/solutions/for-pharmaceutical-companies)
    - [Contract Research Organizations](https://www.acclinate.com/solutions/for-cros)
    - [Partners](https://www.acclinate.com/solutions/community-partners)
- Company 
    - [About Us](https://www.acclinate.com/about)
    - [Careers](https://www.acclinate.com/careers)
    - [News](https://news.acclinate.com)
- Resources 
    - [Resource Library](https://www.acclinate.com/resources)
    - [Blog](https://blog.acclinate.com)
    - [Press Kit](https://www.acclinate.com/press-kit)
    - [Events](https://www.acclinate.com/events)
    - [Glossary](https://www.acclinate.com/glossary)
    - [FAQ](https://www.acclinate.com/faq)
- [Talk to Our Team](https://info.acclinate.com/get-in-touch)

[![Talk to Our Team](https://no-cache.hubspot.com/cta/default/19943632/2e1c34dc-aaa1-43b8-b5f4-469b0db4e302.png)](https://cta-redirect.hubspot.com/cta/redirect/19943632/2e1c34dc-aaa1-43b8-b5f4-469b0db4e302)

[![Acclinate Logo](https://blog.acclinate.com/hs-fs/hubfs/Acclinate_Logo.png?width=500&height=149&name=Acclinate_Logo.png "Acclinate Logo")](https://www.acclinate.com/)

- Products 
    - [**NOWINCLUDED**Acclinate’s B2C community platform
      
      ](https://www.acclinate.com/products/nowincluded-the-community)
    - [**e-DICT**Acclinate’s patented AI-powered technology
      
      ](https://www.acclinate.com/products/e-dict)
- Solutions 
    - [**Pharmaceutical Companies**Community-driven recruitment and real-world insights to support diverse, compliant clinical trials.
      
      ](https://www.acclinate.com/solutions/for-pharmaceutical-companies)
    - [**Contract Research Organization (CRO)**Scalable patient engagement and recruitment solutions that reduce risk and improve enrollment timelines.
      
      ](https://www.acclinate.com/solutions/for-cros)
    - [**Partners**Trusted partnerships that connect research opportunities with the communities they aim to serve.
      
      ](https://www.acclinate.com/solutions/community-partners)
- Company 
    - [**About us**We help clinical research teams reach diverse communities, build trust, and improve trial participation.
      
      ](https://www.acclinate.com/about)
    - [**Careers**Join a mission-driven team advancing inclusive clinical research and community-powered health innovation.
      
      ](https://www.acclinate.com/careers)
- Resources 
    - [**Resources Hub**
      
      ](https://www.acclinate.com/resources)
    - [**Glossary**
      
      ](https://www.acclinate.com/glossary)
    - [**Press Kit**
      
      ](https://www.acclinate.com/press-kit)
    - [**Events**
      
      ](https://www.acclinate.com/events)
    - [**Blog**
      
      ](https://blog.acclinate.com/)
    - [**News**
      
      ](https://news.acclinate.com/)
    - [![](https://cdn.prod.website-files.com/695fbca039298e2117988a78/69e7b588548c7ad7bd8ab0bc_9dd915489696393dc63d7785ee2e52c7_Question%20mark%20image.png)
      
      **FAQs**
      
      ](https://www.acclinate.com/faq)
- [ Contact Us ](https://www.acclinate.com/contact-us)

Stay up to date

 Get news directly in your inbox

Topic

 All

- [Affective Trust ](https://blog.acclinate.com/tag/affective-trust)
- [Announcement ](https://blog.acclinate.com/tag/announcement)
- [Clinical Research Software ](https://blog.acclinate.com/tag/clinical-research-software)
- [Clinical Trial Recruitment Strategies ](https://blog.acclinate.com/tag/clinical-trial-recruitment-strategies)
- [Community ](https://blog.acclinate.com/tag/community)
- [Diversity in Clinical Trials ](https://blog.acclinate.com/tag/diversity-in-clinical-trials)
- [e-DICT™ ](https://blog.acclinate.com/tag/e-dict)
- [FDA Diversity Plan ](https://blog.acclinate.com/tag/fda-diversity-plan)
- [FDA Guidance: Diversity in Clinical Trials ](https://blog.acclinate.com/tag/fda-guidance-diversity-in-clinical-trials)
- [Health Equity ](https://blog.acclinate.com/tag/health-equity)
- [Partnerships ](https://blog.acclinate.com/tag/partnerships)
- [Representation in Healthcare ](https://blog.acclinate.com/tag/representation-in-healthcare)

[Health Equity](https://blog.acclinate.com/topic/health-equity)

# Acclinate wins Anthem Award for diversity, equity, and inclusion

 ‍Birmingham, AL - January 30, 2024 – Acclinate, a trailblazer in advancing health equity through inclusive research, is thrilled to announce its win in the

![Anthem Award for diversity, equity, and inclusion](https://blog.acclinate.com/hubfs/65bd67b47f81a0c18c101e2a_Anthem%20Awards%20Post.png)

 Clinical Trial Diversity: What Does It Really Mean?

 Clinical trials are critical for evaluating the safety and effectiveness of medical devices and pharmaceutical products. The results of trials guide t...

Read More 

<https://blog.acclinate.com/acclinate-wins-anthem-award-for-dei#>

![ Acclinate](https://blog.acclinate.com/hubfs/69b96486c4b036c19f462c19_acclinate-logo.png)

[Acclinate](https://blog.acclinate.com/author/acclinate)

 Acclinate turns trust and data into better representation.

 Share this Post:

[**](https://www.facebook.com/sharer/sharer.php?u=https://blog.acclinate.com/acclinate-wins-anthem-award-for-dei) [**](https://twitter.com/home?status=https://blog.acclinate.com/acclinate-wins-anthem-award-for-dei) [** ](https://www.linkedin.com/shareArticle?mini=true&url=https://blog.acclinate.com/acclinate-wins-anthem-award-for-dei&title=Acclinate%20wins%20Anthem%20Award%20for%20DEI)

Stay up to date

 Get news directly in your inbox

‍*Birmingham, AL - January 30, 2024* – Acclinate, a trailblazer in advancing health equity through inclusive research, is thrilled to announce its [win in the esteemed Diversity, Equity, & Inclusion category at the 3rd Annual Anthem Awards](https://www.anthemawards.com/winners/list/entry/#!diversity-equity-inclusion/community-engagement/achieving-diversity-in-clinical-research-trials-x-acclinate/1982/-1/459914).

Hosted by the International Academy of Digital Arts and Sciences, the Anthem Awards brings together influential figures from various sectors to honor outstanding achievements in purpose-driven initiatives globally. Acclinate is honored to stand tall among impactful projects that are making a meaningful difference in our world.

At Acclinate, we take pride in our innovative approach, merging predictive analytics technology with empowered community building across diverse demographics. This distinctive strategy actively supports pharmaceutical companies in increasing representation in clinical trials while championing inclusivity in broader healthcare initiatives. Our mission is to transform trust and data into products that better serve communities of color.

Tiffany Whitlow, Chief Development Officer, and co-founder of Acclinate, expressed her gratitude, saying, "This accolade underscores our commitment to fostering diversity and health equity in clinical trials. From the beginning, we recognized the need to change the perception of healthcare, particularly concerning the care of minority communities."

As a winner, Acclinate stands among [projects recognized for their game-changing impact](https://www.anthemawards.com/winners/) in various causes, including Diversity; Equity & Inclusion; Education; Art & Culture; Health; Human & Civil Rights; Humanitarian Action & Services; Responsible Technology; and Sustainability, Environment & Climate.

Join us in celebrating this monumental achievement and [get in touch](https://info.acclinate.com/get-in-touch) to learn how Acclinate can support your diversity initiatives<https://chat.openai.com/c/www.acclinate.com>.

Connect with us on [LinkedIn](https://www.linkedin.com/company/acclinateinc/) and immerse yourself in the NOWINCLUDED community, built for healthier communities of color, at[ NOWINCLUDED.com](https://chat.openai.com/c/www.NOWINCLUDED.com).

## Recent Posts

[![Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World](https://blog.acclinate.com/hubfs/mature-female-patient-at-doctors-appointment-2026-01-08-06-10-47-utc.webp) 

](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world)

<https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world>

[- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials)

](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world)

[ Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World ](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world)

 June 25, 2026

 3 Min Read

 Drug development economics are changing. Sponsors are increasingly relying on a single pivotal trial to support approval. Though the goal of this appr...

Read More

[![Clinical Trial Generalizability: What Regulators Will Scrutinize Next](https://blog.acclinate.com/hubfs/woman-visiting-dermatologist-2026-01-08-22-23-31-utc.webp) 

](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next)

<https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next>

[- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials)

](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next)

[ Clinical Trial Generalizability: What Regulators Will Scrutinize Next ](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next)

 June 25, 2026

 3 Min Read

 For years, generalizability was framed as a methodological concern. Reviewers debated whether results could reasonably extend beyond a trial’s enrolle...

Read More

[![Site Engagement Index (SEI): Measuring What Actually Builds Trust](https://blog.acclinate.com/hubfs/computer-screen-trading-and-back-with-charts-hom-2026-01-09-09-28-19-utc.webp) 

](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust)

<https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust>

[- [Clinical Research Software](https://blog.acclinate.com/news/tag/clinical-research-software)

](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust)

[ Site Engagement Index (SEI): Measuring What Actually Builds Trust ](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust)

 June 25, 2026

 3 Min Read

 Clinical research lacks anything but metrics. Enrollment targets, site activation timelines, and digital engagement rates are tracked closely across s...

Read More

[![](https://blog.acclinate.com/hubfs/Imported_Blog_Media/6567a9f90c0cf111067913e2_Merck%20Pop%20Up2.png) 

](https://blog.acclinate.com/acclinate-collaborates-with-merck-to-increase-clinical-trial-diversity)

<https://blog.acclinate.com/acclinate-collaborates-with-merck-to-increase-clinical-trial-diversity>

<https://blog.acclinate.com/acclinate-collaborates-with-merck-to-increase-clinical-trial-diversity>[ Acclinate to support Merck's oncology clinical trials ](https://blog.acclinate.com/acclinate-collaborates-with-merck-to-increase-clinical-trial-diversity)

 June 24, 2026

 1 Min Read

 Acclinate, an expert in health equity through inclusive research, is collaborating with Merck, known as MSD outside the United States and Canada, to h...

Read More

[![Why Trial Diversity Is Now a Risk Management Strategy](https://blog.acclinate.com/hubfs/Why-Trial-Diversity-Is-Now-a-Risk-Management-Strategy.jpg) 

](https://blog.acclinate.com/why-trial-diversity-is-now-a-risk-management-strategy)

<https://blog.acclinate.com/why-trial-diversity-is-now-a-risk-management-strategy>

[- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials)

](https://blog.acclinate.com/why-trial-diversity-is-now-a-risk-management-strategy)

[ The New Control Lever: Why Trial Diversity Is Now a Risk Management Strategy ](https://blog.acclinate.com/why-trial-diversity-is-now-a-risk-management-strategy)

 March 2, 2026

 3 Min Read

 For years, conversations around trial diversity were framed as ethical or reputational concerns. That framing no longer reflects regulatory reality.

Read More

[![Acclinate’s NOWINCLUDED: Turning Community Insights Into Research Equity](https://blog.acclinate.com/hubfs/AdobeStock_470269560.webp) 

](https://blog.acclinate.com/acclinates-nowincluded-turning-community-insights-into-research-equity)

<https://blog.acclinate.com/acclinates-nowincluded-turning-community-insights-into-research-equity>

[- [Community](https://blog.acclinate.com/news/tag/community)

](https://blog.acclinate.com/acclinates-nowincluded-turning-community-insights-into-research-equity)

[ Acclinate’s NOWINCLUDED: Turning Community Insights Into Research Equity ](https://blog.acclinate.com/acclinates-nowincluded-turning-community-insights-into-research-equity)

 February 16, 2026

 3 Min Read

 Clinical research equity efforts originate with good intentions. But they often hit a roadblock in practice: communities are asked to participate in h...

Read More

[![How Acclinate’s e-DICT™ Technology Builds Real-Time Community Trust](https://blog.acclinate.com/hubfs/AdobeStock_1631551849.webp) 

](https://blog.acclinate.com/how-acclinates-e-dict-technology-builds-real-time-community-trust)

<https://blog.acclinate.com/how-acclinates-e-dict-technology-builds-real-time-community-trust>

[- [Community](https://blog.acclinate.com/news/tag/community)

](https://blog.acclinate.com/how-acclinates-e-dict-technology-builds-real-time-community-trust)

[ How Acclinate’s e-DICT™ Technology Builds Real-Time Community Trust ](https://blog.acclinate.com/how-acclinates-e-dict-technology-builds-real-time-community-trust)

 February 9, 2026

 3 Min Read

 Reaching underrepresented communities in healthcare research has never been simple. Participation decisions are shaped by lived experience, historical...

Read More

[![Data-Driven Inclusion](https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/Acclinate-Data-Driven-Inclusion.jpg) 

](https://blog.acclinate.com/data-driven-inclusion-predictive-analytics-for-trial-enrollment)

<https://blog.acclinate.com/data-driven-inclusion-predictive-analytics-for-trial-enrollment>

[- [Clinical Research Software](https://blog.acclinate.com/news/tag/clinical-research-software)

](https://blog.acclinate.com/data-driven-inclusion-predictive-analytics-for-trial-enrollment)

[ Data-Driven Inclusion: Predictive Analytics for Trial Enrollment ](https://blog.acclinate.com/data-driven-inclusion-predictive-analytics-for-trial-enrollment)

 February 2, 2026

 2 Min Read

 Subpar enrollment remains one of the most common causes of trial delays. But sponsors often miss a key factor: underrepresentation. Lack of diversity ...

Read More

[![Exploring Diversity in Clinical Research With Acclinate](https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/Exploring-Diversity-in-Clinical-Research-With-Acclinate.jpg) 

](https://blog.acclinate.com/exploring-diversity-in-clinical-research-with-acclinate)

<https://blog.acclinate.com/exploring-diversity-in-clinical-research-with-acclinate>

[- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials)

](https://blog.acclinate.com/exploring-diversity-in-clinical-research-with-acclinate)

[ Exploring Diversity in Clinical Research With Acclinate ](https://blog.acclinate.com/exploring-diversity-in-clinical-research-with-acclinate)

 January 26, 2026

 3 Min Read

 Diversity in clinical research remains a widely discussed goal, yet progress has been uneven. Trials still grapple with subpar representation, limited...

Read More

[![Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World](https://blog.acclinate.com/hubfs/mature-female-patient-at-doctors-appointment-2026-01-08-06-10-47-utc.webp)

 June 25, 2026 

 Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World

Read More

](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world)

[![Clinical Trial Generalizability: What Regulators Will Scrutinize Next](https://blog.acclinate.com/hubfs/woman-visiting-dermatologist-2026-01-08-22-23-31-utc.webp)

 June 25, 2026 

 Clinical Trial Generalizability: What Regulators Will Scrutinize Next

Read More

](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next)

[![Site Engagement Index (SEI): Measuring What Actually Builds Trust](https://blog.acclinate.com/hubfs/computer-screen-trading-and-back-with-charts-hom-2026-01-09-09-28-19-utc.webp)

 June 25, 2026 

 Site Engagement Index (SEI): Measuring What Actually Builds Trust

Read More

](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust)

![Woman wearing Acclinate Shirt](https://blog.acclinate.com/hs-fs/hubfs/layer1_image.webp?width=1600&height=1068&name=layer1_image.webp)

![Medical Research Software e-DICT](https://blog.acclinate.com/hs-fs/hubfs/layer2_image.webp?width=885&height=885&name=layer2_image.webp) ![layer2.2_image](https://blog.acclinate.com/hs-fs/hubfs/layer2.2_image.webp?width=1505&height=1197&name=layer2.2_image.webp)

![layer3_image](https://blog.acclinate.com/hs-fs/hubfs/layer3_image.webp?width=1600&height=1067&name=layer3_image.webp)

## Ready to Measure Your True Impact?

 Partner with Acclinate to turn mission into measurable, data-driven action.

[ Get Started ](https://www.acclinate.com/contact-us)

[![Acclinate Logo Reversed](https://blog.acclinate.com/hs-fs/hubfs/footer_logo.png?width=1600&height=398&name=footer_logo.png "Acclinate Logo Reversed")](https://www.acclinate.com/)

- Products
- [NOWINCLUDED](https://www.acclinate.com/products/nowincluded-the-community)
- [e-DICT](https://www.acclinate.com/products/e-dict)

- Solutions
- [Pharmaceutical Companies](https://www.acclinate.com/solutions/for-pharmaceutical-companies)
- [CROs](https://www.acclinate.com/solutions/for-cros)
- [Community Partners](https://www.acclinate.com/solutions/community-partners)

- Resources
- [Resources Hub](https://www.acclinate.com/resources)
- [Glossary](https://www.acclinate.com/glossary)
- [Press Kit](https://www.acclinate.com/press-kit)
- [Events](https://www.acclinate.com/events)
- [News](https://news.acclinate.com/)
- [Blog](https://blog.acclinate.com/)
- [FAQs](https://www.acclinate.com/faq)

- Company
- [About us](https://www.acclinate.com/about)
- [Careers](https://www.acclinate.com/careers)
- [Contact Us](https://www.acclinate.com/contact-us)

- Follow Us
- [** Linkedin](https://www.linkedin.com/company/acclinateinc/)

- [Privacy Policy](https://www.acclinate.com/privacy)
- [Terms of Service](https://www.acclinate.com/terms-of-use-acclinate)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Acclinate",
    "url" : "https://blog.acclinate.com/author/acclinate"
  },
  "dateModified" : "2025-08-04T20:26:30.188Z",
  "datePublished" : "2024-02-02T06:48:00.000Z",
  "headline" : "Acclinate wins Anthem Award for DEI",
  "image" : [ "https://blog.acclinate.com/hubfs/65bd67b47f81a0c18c101e2a_Anthem%20Awards%20Post.png" ],
  "mainEntityOfPage" : {
    "@id" : "https://blog.acclinate.com/acclinate-wins-anthem-award-for-dei",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://blog.acclinate.com/hubfs/Acclinate-logo.png"
    },
    "name" : "Acclinate"
  }
}
```